Agenus Inc (AGEN) – Strategy, SWOT and Corporate Finance Report

Agenus Inc (AGEN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Agenus Inc (Agenus), formerly, Antigenics Inc, is a clinical-stage immuno-oncology company that discovers, develops and commercializes immunotherapeutics for the treatment of various types of cancers and infectious diseases. The company’s pipeline portfolio encompasses vaccines for glioblastoma, genital herpes, and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The company's technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Scope

• Detailed information on Agenus Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Agenus Inc in the form of a SWOT analysis

• An in-depth view of the business model of Agenus Inc including a breakdown and examination of key business segments

• News about Agenus Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Agenus Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Agenus Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Agenus Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Janssen Pharmaceuticals Inc

Dynavax Technologies Corp

Amgen Inc

Maxinovel Pharmaceuticals

Biocad

Qilu Pharmaceutical Co Ltd

AbbVie Inc

3D Medicines Inc

CSPC ZhongQi Pharmaceutical Technology Co Ltd

Boehringer Ingelheim International GmbH

Arcus Biosciences Inc

SinoCelltech Group Ltd

Genor BioPharma Co Ltd

Shanghai Henlius Biotech Co., Ltd.

Novartis AG

MacroGenics Inc

Incyte Corp

Checkpoint Therapeutics Inc

MabSpace Biosciences (Suzhou) Co Ltd

ImmuneOncia Therapeutics Inc

Shandong New Time Pharmaceutical Co Ltd

TVAX Biomedical Inc

Green Cross Cell Corp

EOM Pharmaceuticals Holdings Inc

Northwest Biotherapeutics Inc

Celldex Therapeutics Inc

Juvaris BioTherapeutics Inc

Idera Pharmaceuticals Inc

Dynavax Technologies Corp

Oxford BioMedica Plc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Agenus Inc - Key Facts

Agenus Inc - Key Employees

Agenus Inc - Key Employee Biographies

Agenus Inc - Major Products and Services

Agenus Inc - History

Agenus Inc - Company Statement

Agenus Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Agenus Inc - Business Description

Geographical Segment: Rest Of World

Performance

Geographical Segment: United States

Performance

R&D Overview

Agenus Inc - Corporate Strategy

Agenus Inc - SWOT Analysis

SWOT Analysis - Overview

Agenus Inc - Strengths

Agenus Inc - Weaknesses

Agenus Inc - Opportunities

Agenus Inc - Threats

Agenus Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Agenus Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 09, 2023: Agenus Provides Corporate Update and First Quarter 2023 Financial Results

Mar 14, 2023: Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives

Mar 11, 2023: Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVB

Feb 28, 2023: Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial Report

Nov 08, 2022: Agenus Provides Corporate Update and Third Quarter 2022 Financial Report

Oct 25, 2022: Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report

Sep 12, 2022: Agenus Makes Senior Regulatory and Clinical Appointments

Aug 09, 2022: Agenus Provides Corporate Update and Second Quarter 2022 Financial Report

Jul 27, 2022: Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report

May 31, 2022: Agenus advances portfolio with 6 Clinical Collaborations

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Agenus Inc, Key Facts

Agenus Inc, Key Employees

Agenus Inc, Key Employee Biographies

Agenus Inc, Major Products and Services

Agenus Inc, History

Agenus Inc, Subsidiaries

Agenus Inc, Key Competitors

Agenus Inc, Ratios based on current share price

Agenus Inc, Annual Ratios

Agenus Inc, Annual Ratios (Cont…1)

Agenus Inc, Annual Ratios (Cont…2)

Agenus Inc, Interim Ratios

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Agenus Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Agenus Inc, Performance Chart (2018 – 2022)

Agenus Inc, Ratio Charts

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Agenus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports